Use of streptokinase in four dogs with thrombosis

Journal of the American Veterinary Medical Association

Volumn 209, Issue 4, 1996, Pages 780-785

  Ramsey, Cynthia C ^a,c   Burney, Derek P ^b,d   Macintire, Douglass K ^b   Finn Bodner, Susan ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b AUBURN UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; WARFARIN;

ARTICLE; DOG; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; VETERINARY MEDICINE;

ADRENOCORTICAL HYPERFUNCTION; ANIMALS; ANTICOAGULANTS; CARDIOMYOPATHY, DILATED; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOG DISEASES; DOGS; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HYPERTENSION; MALE; PROTEIN-LOSING ENTEROPATHIES; STREPTOKINASE; THROMBOSIS;

CANIS FAMILIARIS;

EID: 0029742281     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Campbell SL, Forrester SD, Johnston SA, et al. Chylothorax associated with constrictive pericarditis in a dog. J Am Vet Med Assoc 1995;206:1561-1564.
2. Boudreaux MK, Dillon AR, Spano JS. Enhanced platelet reactivity in heartworm-infected dogs. Am J Vet Res 1989;50:1544-1547.
3. Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol 1993;30:28-35.
4. Feldman BF, Rasedee A, Feldman EC. Haemostatic abnormalities in canine Cushing's syndrome. Res Vet Sci 1986;41:228-230.
5. Schafer AI. The hypercoagulable states. Ann Intern Med 1985;102:814-828.
6. Feldman EC. Adrenal gland disease. In: Etlinger SJ, ed. Textbook of veterinary internal medicine. 3rd ed. Philadelphia: WB Saunders Co, 1989;1721-1774.
7. Patrassi GM, Dal Bo Zanon R, Boscaro M, et al. Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 1985;54:518-520.
8. Stead RB. The hypercoagulable state. In: Goldhaber, ed. Pulmonary embolism and deep venous thrombosis. Philadelphia: WB Saunders Co, 1985;161-178.
9. Van Winkle TJ, Hackner SG, Liu SM. Clinical and pathological features of aortic thromboembolism in 36 dogs. J Vet Emerg Crit Care 1993;3:13-21.
10. Daniel GB, Wantschek L, Bright R, et al. Diagnosis of aortic lhromboembolism in two dogs with radionuclide angiography. Vet Radiol 1990;31:182-185.
11. Takada Y, Takada A. The mechanisms of the activation of plasminogen by streptokinase and urokinase. Adv Exp Biol Med 1989; 281:223-234.
12. Marder VJ, Sherry S. Thrombolytic therapy: current status (first of two parts). N Engl J Med 1988;318:1512-1520.
13. Marder VJ, Bell WR. Fibrinolytic therapy. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis. Philadelphia: JB Lippincott Co, 1987;1393-1437.
14. Killingsworth CR, Eyster GE, Adams T, et al. Streptokinase treatment of cats with experimentally induced aortic thrombosis. Am J Vet Res 1986;47:1351-1359.
15. Elliott JM, Cross DB, Cederholm-Williams SA, et al. Neutralizing antibodies to streptokinase four years after intravenous thrombolylic therapy. Am J Cardiol 1993;71:640-645.
16. Buchalter MB, Suntharalingam G, Jennings I, et al. Streptokinase resistance: when might streptokinase administration be ineffective? Br Heart J 1992;68:449-453.
17. Califf RM, Fortin DF, Tenaglia AN, et al. Clinical risks of thrombolylic therapy. Am J Cardiol 1992;69:12A-20A.
18. Augusto BF, Berkowitz SD, Zimmerman TS, et al. Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction. Blood 1992;79:38-44.
19. Bertolino G, Noris P, Previtali M, et al. Platelet function after in vivo and in vitro treatment with thrombolytic agents. Am J Cardiol 1992;69:457-461.
20. Hoffmann JJML, Janssen WCM. Interactions between thrombolytic agents and platelets: effects of plasmin on platelet glycoproteins Ib and IIb/IIIa. Thromb Res 1992;67:711-719.
21. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
22. Montrucchio G, Alloatti G, Mariano F, et al. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits. Circ Res 1993;72:658-670.